Antithrombotic therapy in peripheral arterial occlusive disease.
Jackson
M R
MR
Department of Surgery, University of Texas Southwestern Medical Center, Dallas 75235-9157, USA.
Clagett
G P
GP
D015906:Angioplasty, Balloon, Coronary; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D001241:Aspirin / Q000627:therapeutic use; D000077144:Clopidogrel; D016894:Endarterectomy, Carotid; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006083:Graft Occlusion, Vascular / Q000517:prevention & control; D006801:Humans; D007866:Leg / Q000098:blood supply; D016491:Peripheral Vascular Diseases / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin